InsidersTradesSigma
基于 1 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
无可用的信号评分。
Discover the full record of transactions filed by Hackman Jeffrey S.. Director active across 2 companies, notably Comera Life Sciences Holdings, Inc.. Aggregated, 10 filings have been published. Split: 2 buys · 0 sell. Total volume traded: €6k. History available since 16 May 2025. The latest transaction was disclosed on 31 August 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
10 条申报中的 10 条
Jeffrey S. Hackman is a declarant linked to Fennec Pharmaceuticals INC. as Chief Executive Officer and to Comera Life Sciences Holdings, Inc. as See Remarks. He has 9 filings in total, and among the recent filings we hold, the period runs from 2022-09-12 to 2026-08-03, with buys of EUR 6242 and sells of EUR 0, and the most common transaction nature being option exercise.